cidofovir anhydrous has been researched along with Carcinoma, Intraepithelial in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
| Burgos, J; Campany, D; Curran, A; Falcó, V; Garcia, J; Landolfi, S | 1 |
| Coroneo, MT; Ip, MH | 1 |
| Bryant, D; Fiander, AN; Hibbitts, S; Hurt, CN; Jones, SEF; Powell, N; Tristram, AJ | 1 |
| Carucci, M; Fiander, A; Hurt, CN; Jones, S; Madden, TA; Naik, R; Nordin, AJ; Powell, N; Tristram, A | 1 |
| Helm, CW | 1 |
| Mahner, S; Wölber, L | 1 |
| Dutton, P; Fiander, A; Griffiths, G; Hibbitts, S; Hurt, CN; Jones, S; Madden, T; Man, S; Naik, R; Nordin, AJ; Powell, N; Tristram, A | 1 |
| Bryant, A; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L | 1 |
| Bryant, A; Chakrabarti, M; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L | 1 |
| Álvarez-Gallego, M; Arribas, JR; Beato, MJ; Bernardino, JI; Díaz-Almirón, M; Feíto, M; Feltes, R; González-García, J; Herranz, P; Pérez-Molina, JA; Sendagorta, E; Yllescas, M | 1 |
| Aboulafia, D; Berry, JM; Da Costa, M; Darragh, TM; Einstein, MH; Goldstone, SE; Jay, N; Lee, JY; Palefsky, JM; Panther, L; Stier, EA; Wilkin, T | 1 |
| Nathan, M | 1 |
| Blauvelt, A; Sanchez, S; Toro, JR; Turiansky, G | 1 |
| Fiander, A; Tristram, A | 1 |
| Crickx, B; Descamps, V; Duval, X; Grossin, M; Leport, C | 1 |
| Bossens, M; DeClercq, E; Freedman, R; Kavanagh, J; Koonsaeng, S; Kudelka, A; Sittisomwong, T; Snoeck, R; Verschraegen, C | 1 |
3 review(s) available for cidofovir anhydrous and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Medical interventions for high-grade vulval intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Female; Humans; Imiquimod; Indoles; Organophosphonates; Randomized Controlled Trials as Topic; Vulvar Neoplasms | 2015 |
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Disease Progression; Female; Humans; Imiquimod; Indoles; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Photochemotherapy; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2016 |
Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.
Topics: Administration, Cutaneous; Administration, Topical; Antiviral Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Herpes Simplex; Humans; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Infectious; Skin Neoplasms; Smallpox; Warts | 2003 |
5 trial(s) available for cidofovir anhydrous and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN).
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Vulvar Neoplasms | 2018 |
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.
Topics: Adult; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Cidofovir; Cytosine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Imiquimod; Middle Aged; Neoplasm Grading; Organophosphonates; Vulvar Neoplasms | 2014 |
Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.
Topics: Administration, Topical; Adult; Antiviral Agents; Anus Neoplasms; Biopsy; Carcinoma in Situ; Cidofovir; Cytosine; HIV Infections; Humans; Male; Organophosphonates; Papillomavirus Infections; Pilot Projects; Treatment Outcome | 2016 |
Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.
Topics: Acquired Immunodeficiency Syndrome; Administration, Cutaneous; Adult; Aged; Antiviral Agents; Anus Neoplasms; Carcinoma in Situ; CD4 Lymphocyte Count; Cidofovir; Cyclin-Dependent Kinase Inhibitor p16; Cytosine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Proteins; Organophosphonates; Perineum; Prospective Studies; Vulvar Neoplasms | 2013 |
Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aged; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Organophosphonates; Vulvar Neoplasms | 2005 |
9 other study(ies) available for cidofovir anhydrous and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statem
Topics: Carcinoma in Situ; Cidofovir; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Vulvar Neoplasms | 2022 |
Effectiveness of topical cidofovir for treatment of refractory anal high-grade squamous intraepithelial lesion.
Topics: Anus Neoplasms; Carcinoma in Situ; Cidofovir; HIV Infections; Homosexuality, Male; Humans; Male; Prospective Studies; Squamous Intraepithelial Lesions; Treatment Outcome | 2023 |
Treatment of Previously Refractory Ocular Surface Squamous Neoplasia With Topical Cidofovir.
Topics: Administration, Ophthalmic; Aged; Carcinoma in Situ; Cidofovir; Conjunctival Neoplasms; Cytosine; Humans; Male; Neoplasm Recurrence, Local; Organophosphonates | 2017 |
Human Papillomavirus DNA Methylation Predicts Response to Treatment Using Cidofovir and Imiquimod in Vulval Intraepithelial Neoplasia 3.
Topics: Aminoquinolines; Biomarkers; Carcinoma in Situ; Cidofovir; Cytosine; DNA Methylation; DNA, Viral; Drug Therapy, Combination; Female; Genes, Viral; Humans; Imiquimod; Neoplasm Staging; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Promoter Regions, Genetic; ROC Curve; Treatment Outcome; Vulvar Neoplasms | 2017 |
Is cidofovir a better treatment than imiquimod for high-grade vulval intraepithelial neoplasia?
Topics: Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Vulvar Neoplasms | 2018 |
Surgery or topical therapy for vulval intraepithelial neoplasia.
Topics: Aminoquinolines; Carcinoma in Situ; Cidofovir; Cytosine; Female; Humans; Imiquimod; Organophosphonates; Vulvar Neoplasms | 2014 |
Treatment of anal intraepithelial neoplasia: has it come of age?
Topics: Antiviral Agents; Anus Neoplasms; Carcinoma in Situ; Cidofovir; Cytosine; Female; HIV Infections; Humans; Male; Ointments; Organophosphonates; Papillomavirus Infections | 2013 |
Topical cidofovir for bowenoid papulosis in an HIV-infected patient.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Cidofovir; Cytosine; HIV Infections; Humans; Male; Organophosphonates; Organophosphorus Compounds | 2001 |
Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.
Topics: Administration, Oral; Administration, Topical; Adult; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Drug Resistance, Multiple; Female; Humans; Injections, Subcutaneous; Interferons; Isotretinoin; Neoplasm Recurrence, Local; Organophosphonates; Organophosphorus Compounds; Uterine Cervical Dysplasia; Vulvar Neoplasms | 2001 |